Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2026-01-02 @ 9:58 AM
Study NCT ID:
NCT01385566
Status:
COMPLETED
Last Update Posted:
2016-06-23
First Post:
2011-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2013-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05
Completion Date Type:
ACTUAL
First Submit Date:
2011-06-28
First Submit QC Date:
None
Study First Post Date:
2011-06-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-12-11
Results First Submit QC Date:
None
Results First Post Date:
2013-02-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-19
Last Update Post Date:
2016-06-23
Last Update Post Date Type:
ESTIMATED